Viewing Study NCT06492395

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:20 PM
Ignite Modification Date: 2026-01-26 @ 12:57 AM
Study NCT ID: NCT06492395
Status: RECRUITING
Last Update Posted: 2025-01-29
First Post: 2024-07-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma Non-resectable View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hepatocellular carcinoma View
None lenvatinib View
None transarterial chemoembolization View
None drug-eluting bead View
None hepatic arterial infusion chemotherapy View
None portal vein tumor thrombosis View